Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
$120,000.00
$120,000.00
$120,000.00
$120,000.00
N/A0.01N/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$5.88
-4.0%
$7.25
$5.86
$14.62
$297.13M1.03555,237 shs789,523 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00%0.00%0.00%0.00%0.00%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
0.00%-13.99%-22.23%-26.71%-19.17%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
$120,000.00
$120,000.00
$120,000.00
$120,000.00
N/A0.01N/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$5.88
-4.0%
$7.25
$5.86
$14.62
$297.13M1.03555,237 shs789,523 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00%0.00%0.00%0.00%0.00%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
0.00%-13.99%-22.23%-26.71%-19.17%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00
N/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest NUS and BTCA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/13/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
UpgradeStrong SellHold
3/2/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
DowngradeHoldStrong Sell
(Data available from 5/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$1.49B0.19$2.31 per share2.54$16.71 per share0.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$160.20M$1.105.104.45N/A3.78%7.47%4.21%8/6/2026 (Estimated)

Latest NUS and BTCA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.15$0.14-$0.01$0.04$329.70 million$320.61 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.244.00%-30.69%21.82%N/A

Latest NUS and BTCA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
quarterly$0.063.41%5/29/20265/29/20266/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
0.26
2.03
1.34

Institutional Ownership

CompanyInstitutional Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
82.84%

Insider Ownership

CompanyInsider Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
41.40%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
126N/AN/ANot Optionable
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2,80048.55 million47.19 millionOptionable

Recent News About These Companies

Nu Skin Enterprises Q1 Earnings Call Highlights
Nu Skin (NUS) Q1 2026 Earnings Transcript
Nu Skin Enterprises Reports First Quarter Results
Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Appoints Chayce Clark as COO
Nu Skin: Patience Is Still Advised
Nu Skin Still Has Long-Term Turnaround Potential

Media Sentiment Over Time

Bactolac Pharmaceutical stock logo

Bactolac Pharmaceutical OTCMKTS:BTCA

$120,000.00 0.00 (0.00%)
As of 09/18/2017

Bactolac Pharmaceutical, Inc. engages in the research, development and commercialization of vitamins and neutraceuticals. It offers nutritional supplements and shake powders, resveratrol, probiotics, multivitamins, antioxidant products, sports and hormone supplements, and weight loss and detoxification drugs. The company was founded by Pailla Malla Reddy in 1995 and is headquartered in Hauppauge, NY.

Nu Skin Enterprises stock logo

Nu Skin Enterprises NYSE:NUS

$5.88 -0.25 (-4.00%)
Closing price 03:59 PM Eastern
Extended Trading
$5.86 -0.02 (-0.34%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.